AMP-activated protein kinase confers protection against TNF-{alpha}-induced cardiac cell death.
about
Research progress of cardioprotective agents for prevention of anthracycline cardiotoxicity.Glucocorticoid signaling in the heart: A cardiomyocyte perspectiveMetformin protects cardiomyocyte from doxorubicin induced cytotoxicity through an AMP-activated protein kinase dependent signaling pathway: an in vitro studyDual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosisUpstream molecular signaling pathways of p27(Kip1) expression: effects of 4-hydroxytamoxifen, dexamethasone, and retinoic acids.Dexamethasone-induced autophagy mediates muscle atrophy through mitochondrial clearance.Berberine inhibits norepinephrine-induced apoptosis in neonatal rat cardiomyocytes via inhibiting ROS-TNF-α-caspase signaling pathway.Cardiac-specific leptin receptor deletion exacerbates ischaemic heart failure in mice.Bioenergy sensing in the brain: the role of AMP-activated protein kinase in neuronal metabolism, development and neurological diseasesEndogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-α/JNK.A novel mechanism by which SDF-1β protects cardiac cells from palmitate-induced endoplasmic reticulum stress and apoptosis via CXCR7 and AMPK/p38 MAPK-mediated interleukin-6 generation.Adenosine monophosphate-activated protein kinase is required for pulmonary artery smooth muscle cell survival and the development of hypoxic pulmonary hypertensionDisruption of calpain reduces lipotoxicity-induced cardiac injury by preventing endoplasmic reticulum stress.Metformin promotes the survival of transplanted cardiosphere-derived cells thereby enhancing their therapeutic effect against myocardial infarction.Tissue-specific actions of glucocorticoids on apoptosis: a double-edged sword.Oxytocin: Old Hormone, New Drug.AMP-activated protein kinase α2 protects against liver injury from metastasized tumors via reduced glucose deprivation-induced oxidative stressBerberine protects against lipopolysaccharide-induced intestinal injury in mice via alpha 2 adrenoceptor-independent mechanisms.Protective effects of AMP-activated protein kinase in the cardiovascular system.Protein kinase C (PKC) participates in acetaminophen hepatotoxicity through c-jun-N-terminal kinase (JNK)-dependent and -independent signaling pathways.AMP-activated protein kinase-α1 as an activating kinase of TGF-β-activated kinase 1 has a key role in inflammatory signals.Cells lacking the fumarase tumor suppressor are protected from apoptosis through a hypoxia-inducible factor-independent, AMPK-dependent mechanism.AMPK attenuates bupivacaine-induced neurotoxicity.AMPK-associated signaling to bridge the gap between fuel metabolism and hepatocyte viability.AMPK and TNF-alpha at the crossroad of cell survival and death in ischaemic heart.Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats.Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia.Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure.
P2860
Q26742059-509326B9-C7E9-49CC-B0DC-5E41C29877EBQ28083936-44919D1D-A286-49BC-B84D-AD51DB0574AFQ28541996-C9C5AC12-F5C8-4BEB-BE62-BA6778EE593BQ28580617-4B4E39CC-A2D7-4A0B-A973-B4E680AEAE6DQ33737205-E0F48EF5-E37C-4577-B442-BB236FF87E8AQ33952822-866E8A99-8436-4BB3-9B9A-BF1EBBA3E716Q34180951-B1969F43-EE7C-45DC-85BE-8E6DD2D8BFABQ34410318-31F7D59D-1E82-4C9E-A1A5-3B5CF716113AQ35695006-6D4B00F8-C5D8-455A-9AAC-D28E873D4197Q35825886-14C7BA05-EC3D-4495-BD78-6273D372B181Q37014884-29C8CCC4-5731-40A1-874E-5B6D241BF8B7Q37297940-884069BC-C02B-4A8D-A67E-C715C0B6C61DQ37344309-421C4044-5A03-43BE-ADF7-BDA3B4AC0861Q37611026-CD93F5BC-E383-4E16-8399-0C732E5CEDE7Q37679245-A9A02FFC-2263-4B72-BE7A-B70054E9313EQ37689872-FA3EDB6E-4982-486B-A07F-607DC2E7C20CQ37691707-912DDC41-7EA0-4858-AB17-AD803A929A80Q37728741-63465077-D716-4635-9151-EFAEB624C067Q37793322-87DCD817-E10E-4295-91AD-691F33126D23Q38923907-027AF2EE-C008-4718-BB2C-47C2B615295BQ39308104-0A594634-AB03-476F-8D63-1CE02F83A54CQ39340083-9315790B-FE59-4C7E-8E5F-BC20FC26C627Q39706835-53F0C560-4E56-4A70-9EAD-EA1AD5CCC638Q42534791-6827DCE9-5C86-4F73-BBAB-39E78BDDA124Q42551470-3D66B32A-BD04-4209-B47D-F17FDC50FD18Q43151456-5162B782-C7D6-4F05-9B5D-FE6AAAAD8C06Q48451001-8B8689EE-1E8F-4F90-885B-3E3ED7CE2E81Q51373277-6857789E-22DE-435E-95CF-B3CEFADB6898
P2860
AMP-activated protein kinase confers protection against TNF-{alpha}-induced cardiac cell death.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
AMP-activated protein kinase c ...... a}-induced cardiac cell death.
@ast
AMP-activated protein kinase c ...... a}-induced cardiac cell death.
@en
type
label
AMP-activated protein kinase c ...... a}-induced cardiac cell death.
@ast
AMP-activated protein kinase c ...... a}-induced cardiac cell death.
@en
prefLabel
AMP-activated protein kinase c ...... a}-induced cardiac cell death.
@ast
AMP-activated protein kinase c ...... a}-induced cardiac cell death.
@en
P2093
P2860
P356
P1476
AMP-activated protein kinase c ...... a}-induced cardiac cell death.
@en
P2093
Ashraf Abrahani
Brian Rodrigues
Girish Kewalramani
James D Johnson
Min Suk Kim
Prasanth Puthanveetil
Sylvia Deppe
P2860
P356
10.1093/CVR/CVP166
P577
2009-05-28T00:00:00Z